A Rapid, Sensitive, and Selective Liquid Chromatography–mass Spectrometry Method for Simultaneous Quantification of Astragaloside IV and Cycloastragenol in Mouse Plasma and Its Application to a Pharmacokinetic Study

Bingshu He,Zhonghua Wang,Lulu Chen,Zhi Zhou,Zeper Abliz
DOI: https://doi.org/10.1016/j.ijms.2018.09.012
IF: 1.934
2018-01-01
International Journal of Mass Spectrometry
Abstract:Astragaloside IV is the primary active ingredient of Astragalus membranaceus (Fisch.) Bunge with multiple pharmacological effects and a promising therapeutic agent for a number of diseases such as diabetic nephropathy and heart disease. To study the pharmacokinetics of astragaloside IV in mice, a rapid, sensitive, and selective liquid chromatography-mass spectrometry method was developed for the simultaneous quantification of astragaloside IV and its main bioactive metabolite, cycloastragenol. Samples were prepared using only 20 mu L of mouse plasma and digoxin as an internal standard. After protein precipitation, the supernatant was treated using a phospholipid removal plate to remove ion-suppressive phospholipids. The analytes and internal standard in the filtered solutions were separated on a C-18 column and detected under positive ion and selected ion monitoring mode within just 3 min. The assay exhibited good linearity in the concentration range 1-200 ng/mL. The intra- and interday precisions expressed as relative standard deviations were all below 8.6%, and the accuracy expressed as a relative error was <= 8.8%. The method was successfully applied to a pharmacokinetic study of healthy mice upon administration of 30 mg/kg/d astragaloside IV. (C) 2018 Elsevier B.V. All rights reserved.
What problem does this paper attempt to address?